WuXi PharmaTech Announces Third Quarter 20...() 1431 (713) Income befo...),Health

Income before income taxes 8,825 2,860 22,279 5,216

Income taxes (178) (29) (507) (331)

Net income 8,647 2,831 21,772 4,885

Income (loss) attributable

to holders of ADS (Note

2):

Basic 6,868 1,701 8,431 (38,453)

Diluted 6,898 1,701 8,431 (38,453)

Basic earnings (loss) per

ADS (Note 2) 0.15 0.05 0.27 (1.28)

Diluted earnings (loss)

per ADS (Note 2) 0.12 0.05 0.22 (1.28)

Weighted average ADS

outstanding - basic (Note

2) 44,774,893 31,132,500 30,860,969 30,131,581

Weighted average ADS

outstanding - diluted

(Note 2) 55,496,657 35,794,882 37,772,585 30,131,581

Note 2: One (1) ADS equals eight (8) ordinary shares

WUXI PHARMATECH (CAYMAN) INC.

RECONCILIATION OF NON-GAAP TO GAAP

(in thousands of US Dollars, except per ADS data)

(Unaudited)

Three Months Ended September 30,

2007 2006

GAAP net income 8,647 2,831

Share based compensation expenses 1,475 2,492

Non-GAAP net income 10,122 5,323

Non-GAAP net income:

Attributable to holders of ADS 8,039 3,199

Attributable to holders of

preference shares 2,083 2,124

'/>"/>